GenomicTree Co Ltd (GenomicTree) is a medical device company. It develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic products. Its products are used in the detection of colorectal, lung and bladder cancer. GenomicTree's products include novel epigenetic biomarkers and non-invasive accurate cancer detection products. The company's other products comprise infectious disease detection products, genotypes detection products, methylation profiling systems, single tube products, oncology treatment products, and others. GenomicTree offers services such as assay development, clinical validation, gene expression microarray services, miRNA microarray, methylation microarray, pyrosequencing, methylation, and methylation assay services. The company caters to the pharmaceutical and diagnostic sectors. GenomicTree is headquartered in Daejeon, South Korea.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GenomicTree Co Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- GenomicTree Co Ltd Company Overview
- GenomicTree Co Ltd Company Snapshot
- GenomicTree Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- GenomicTree Co Ltd - Pipeline Analysis Overview
- GenomicTree Co Ltd - Key Facts
- GenomicTree Co Ltd - Major Products and Services
- GenomicTree Co Ltd Pipeline Products by Development Stage
- GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status
- GenomicTree Co Ltd Pipeline Products Overview
- AccuraDTect SARS-CoV-2 RT-qPCR Kit
- AccuraDTect SARS-CoV-2 RT-qPCR Kit Product Overview
- AccuraTect EGFR
- AccuraTect EGFR Product Overview
- AccuraTect-BRAF
- AccuraTect-BRAF Product Overview
- EarlyTect Bladder Cancer Test
- EarlyTect Bladder Cancer Test Product Overview
- EarlyTect Bladder Cancer Test Clinical Trial
- EarlyTect Breast Cancer
- EarlyTect Breast Cancer Product Overview
- EarlyTect Cervical Cancer
- EarlyTect Cervical Cancer Product Overview
- EarlyTect Colon Cancer Test
- EarlyTect Colon Cancer Test Product Overview
- EarlyTect Colorectal Cancer
- EarlyTect Colorectal Cancer Product Overview
- EarlyTect Lung Cancer Test
- EarlyTect Lung Cancer Test Product Overview
- GTPlex Respiratory PyroSeq Assay
- GTPlex Respiratory PyroSeq Assay Product Overview
- Real-Time PCR Respiratory Virus Assay
- Real-Time PCR Respiratory Virus Assay Product Overview
- Screening Test - Cervical Cancer
- Screening Test - Cervical Cancer Product Overview
- GenomicTree Co Ltd - Key Competitors
- GenomicTree Co Ltd - Key Employees
- GenomicTree Co Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- GenomicTree Co Ltd, Recent Developments
- Mar 20, 2024: Genomictree, ‘Earlytech-B’ Designated as Innovative Medical Device by Korea Food and Drug Administration
- Dec 14, 2023: Genomictree Completes Recruiting Patients for Bladder Cancer Early Detection Trials
- May 31, 2023: Genomictree launches LDT service for its bladder cancer diagnostic in US
- May 01, 2023: Promis gets breakthrough device status from FDA for EarlyTect BCD test
- Apr 27, 2023: Genomictree's bladder cancer diagnostic kit receives breakthrough device designation from FDA
- Sep 10, 2021: Promis Dx presents validation data for urine DNA test for bladder cancer detection in Hematuria
- Dec 31, 2020: Daewoong Pharmaceutical Company Indonesia (DPCI) acquires a license to sell COVID-19 Test kit in Indonesia
- Jun 07, 2013: Biomarker Identification May Lead To New Noninvasive Test For Colorectal Cancer Detection, Yonsei University College of Medicine And Genomictree Study
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- GenomicTree Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- GenomicTree Co Ltd Pipeline Products by Equipment Type
- GenomicTree Co Ltd Pipeline Products by Indication
- GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status
- GenomicTree Co Ltd, Key Facts
- GenomicTree Co Ltd, Major Products and Services
- GenomicTree Co Ltd Number of Pipeline Products by Development Stage
- GenomicTree Co Ltd Pipeline Products Summary by Development Stage
- GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status
- GenomicTree Co Ltd Ongoing Clinical Trials Summary
- AccuraDTect SARS-CoV-2 RT-qPCR Kit - Product Status
- AccuraDTect SARS-CoV-2 RT-qPCR Kit - Product Description
- AccuraTect EGFR - Product Status
- AccuraTect EGFR - Product Description
- AccuraTect-BRAF - Product Status
- AccuraTect-BRAF - Product Description
- EarlyTect Bladder Cancer Test - Product Status
- EarlyTect Bladder Cancer Test - Product Description
- EarlyTect Bladder Cancer Test - A Multicenter, Single-blind, Prospective Clinical Trial to Evaluate the Clinical Performance of EarlyTect Bladder Cancer Test in the Urine DNA for Detecting Bladder Cancer Among Hematuria Patients
- EarlyTect Breast Cancer - Product Status
- EarlyTect Breast Cancer - Product Description
- EarlyTect Cervical Cancer - Product Status
- EarlyTect Cervical Cancer - Product Description
- EarlyTect Colon Cancer Test - Product Status
- EarlyTect Colon Cancer Test - Product Description
- EarlyTect Colorectal Cancer - Product Status
- EarlyTect Colorectal Cancer - Product Description
- EarlyTect Lung Cancer Test - Product Status
- EarlyTect Lung Cancer Test - Product Description
- GTPlex Respiratory PyroSeq Assay - Product Status
- GTPlex Respiratory PyroSeq Assay - Product Description
- Real-Time PCR Respiratory Virus Assay - Product Status
- Real-Time PCR Respiratory Virus Assay - Product Description
- Screening Test - Cervical Cancer - Product Status
- Screening Test - Cervical Cancer - Product Description
- GenomicTree Co Ltd, Key Employees
- GenomicTree Co Ltd, Subsidiaries
- Glossary
- GenomicTree Co Ltd Pipeline Products by Equipment Type
- GenomicTree Co Ltd Pipeline Products by Development Stage
- GenomicTree Co Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- SELVAS Healthcare Inc
- Boditech Med Inc
- Standard Diagnostics Inc
